Physician profile
Yicheng Chen
NPI 1124314653
$2,931.19
in general payments reported to CMS, 2019-2025
12 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $18.38 · 2021: $38.09 · 2022: $119 · 2023: $286 · 2024: $669 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,790 · Consulting Fee: $500 · Education: $19.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,790.35 |
| Consulting Fee | $500.00 |
| Education | $19.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $772.80 | 2025 | Triesence, Iheezo |
| Regeneron Healthcare Solutions, INC. | $669.50 | 2019-2025 | Eylea Hd, Eylea |
| Biogen, INC. | $458.61 | 2022-2025 | Byooviz |
| Dutch Ophthalmic, USA | $286.18 | 2019 | |
| Genentech USA, INC. | $246.37 | 2020-2025 | Vabysmo |
| Abbvie INC. | $147.71 | 2023-2025 | Ozurdex |
| Astellas Pharma US INC | $104.48 | 2024-2025 | Izervay |
| Alcon Vision LLC | $94.91 | 2025 | Clareon Panoptix Pro |
| Apellis Pharmaceuticals, INC. | $56.96 | 2024-2025 | Syfovre |
| Allergan, INC. | $37.30 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $32.22 | 2025 | Purified Cortrophin Gel |
| Alimera Sciences, INC. | $24.15 | 2024 | Iluvien, Yutiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yicheng Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.